
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Genentech | Baloxavir marboxil | Xofluza | 2030-06-14 | 2018-10-24 |  |  |
| Roche | Baloxavir marboxil | Xofluza |  | 2021-01-07 | $46.861 M | Y2020 |
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|